News & Updates

Show Multimedia Only

Inclisiran outdoes BPA for LDL-C lowering in high CV risk patients

11 Sep 2026 by

In the phase IV VICTORION-Challenge trial, inclisiran outperforms bempedoic acid (BPA) for lowering LDL-C in individuals with high and very high cardiovascular (CV) risk.

Inclisiran outdoes BPA for LDL-C lowering in high CV risk patients

11 Sep 2026

Upadacitinib shows therapeutic potential in SAPHO syndrome

11 Sep 2026

In the treatment of patients with SAPHO syndrome, the use of upadacitinib appears to confer rapid improvements in musculoskeletal and cutaneous lesions, without serious adverse reactions, according to a retrospective observational study.

Upadacitinib shows therapeutic potential in SAPHO syndrome

11 Sep 2026

Upadacitinib gets high marks in severe alopecia areata trials

10 Sep 2026 by

Treatment with the oral JAK inhibitor upadacitinib appears to lead to substantial hair regrowth in patients with severe alopecia areata, as shown in the two parallel phase III UP-AA1 and UP-AA2 studies.

Upadacitinib gets high marks in severe alopecia areata trials

10 Sep 2026

Short-term PM2.5 exposure ups risk of cardiovascular deaths

10 Sep 2026

Short-term exposure to ambient fine particulate matter (PM2.5) appears to increase the risk of cardiovascular mortality, suggests a study.

Short-term PM2.5 exposure ups risk of cardiovascular deaths

10 Sep 2026

Mediterranean lifestyle, physical activity, sleep tied to better psychological health

10 Sep 2026 by

Adherence to Mediterranean lifestyle, social participation, physical activity, sleep, and sociodemographic and health-related factors all contribute to life satisfaction and psychological distress, suggests a study.

Mediterranean lifestyle, physical activity, sleep tied to better psychological health

10 Sep 2026

Increase in hs-cTnI rare during normal delivery

10 Sep 2026

Assessment of high-sensitivity cardiac troponin I (hs-cTnI) trajectories during the immediate peripartum period hint at delivery as a physiologic cardiovascular “stress test,” according to a study.

Increase in hs-cTnI rare during normal delivery

10 Sep 2026

SHASTA trials boost plozasiran potential in severe hypertriglyceridaemia

10 Sep 2026 by

In the SHASTA-3 and SHASTA-4 trials, quarterly administration of plozasiran reduced triglyceride (TG) levels and acute pancreatitis (AP) events in individuals with severe hypertriglyceridaemia (sHTG; TG ≥500 mg/dL).

SHASTA trials boost plozasiran potential in severe hypertriglyceridaemia

10 Sep 2026

Large study captures risk of poor foetal growth after prenatal antiseizure meds exposure

10 Sep 2026

Prenatal exposure to antiseizure medications is associated with increased risk of poor foetal growth, according to a large prospective study.

Large study captures risk of poor foetal growth after prenatal antiseizure meds exposure

10 Sep 2026

Early SGLT-2 inhibitor therapy may be best for diabetic patients recovering from AKI-D

09 Sep 2026 by

For adult patients with type 2 diabetes who are recovering from dialysis-requiring acute kidney injury (AKI-D), initiating sodium-glucose cotransporter-2 (SGLT-2) inhibitor therapy within 30 days of discharge is associated with fewer adverse kidney events compared with later initiation, as shown in a retrospective study.

Early SGLT-2 inhibitor therapy may be best for diabetic patients recovering from AKI-D

09 Sep 2026

Early discharge of infants with tube feeding not linked to parental distress

09 Sep 2026

Early discharge of very preterm infants with home nasogastric tube (NGT) feeding does not appear to increase psychological distress among parents both at discharge and at 3 months corrected age (CA), suggests a study.

Early discharge of infants with tube feeding not linked to parental distress

09 Sep 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Inclisiran outdoes BPA for LDL-C lowering in high CV risk patients

Inclisiran outdoes BPA for LDL-C lowering in high CV risk patients

Upadacitinib shows therapeutic potential in SAPHO syndrome

Upadacitinib shows therapeutic potential in SAPHO syndrome

Upadacitinib gets high marks in severe alopecia areata trials

Upadacitinib gets high marks in severe alopecia areata trials

Short-term PM2.5 exposure ups risk of cardiovascular deaths

Short-term PM2.5 exposure ups risk of cardiovascular deaths

Mediterranean lifestyle, physical activity, sleep tied to better psychological health

Mediterranean lifestyle, physical activity, sleep tied to better psychological health

Increase in hs-cTnI rare during normal delivery

Increase in hs-cTnI rare during normal delivery

SHASTA trials boost plozasiran potential in severe hypertriglyceridaemia

SHASTA trials boost plozasiran potential in severe hypertriglyceridaemia

Large study captures risk of poor foetal growth after prenatal antiseizure meds exposure

Large study captures risk of poor foetal growth after prenatal antiseizure meds exposure

Early SGLT-2 inhibitor therapy may be best for diabetic patients recovering from AKI-D

Early SGLT-2 inhibitor therapy may be best for diabetic patients recovering from AKI-D

Early discharge of infants with tube feeding not linked to parental distress

Early discharge of infants with tube feeding not linked to parental distress